Pfizer's Kindler Joins BIO Board of Directors

March 22, 2007
BioPharm International Editors

The Biotechnology Industry Organization (BIO, Washington, DC, www.bio.org) has elected Pfizer (New York, NY, www.pfizer.com) Chairman and CEO Jeffrey B. Kindler to BIO's board of directors.

The Biotechnology Industry Organization (BIO, Washington, DC, www.bio.org) has elected Pfizer (New York, NY, www.pfizer.com) Chairman and CEO Jeffrey B. Kindler to BIO’s board of directors. Kindler will replace Fred Telling, VP of corporate policy and strategic management, who had served on the BIO Board for 11 years, and is retiring from Pfizer this year. Kindler was appointed CEO and elected to Pfizer’s board of directors in 2006.

Related Content:

News